- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Lexicon Pharmaceuticals Inc+ Add to Watchlist
LXRX:US1.0400 USD 0.0100 0.97%
As of 20:10:00 ET on 04/20/2015.
Company Profile for Lexicon Pharmaceuticals Inc (LXRX)
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches treatments for diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders, and ophthalmic disease.
Lexicon Pharmaceuticals Inc
Key Executives for Lexicon Pharmaceuticals Inc (LXRX)
|Lonnel CoatsPresident/CEO||Jeffrey L WadeExev VP:Corporate/ CFO|
|Pablo LapuertaExev VP/Chief Medical Officer||Alan J MainExev VP:CMC & Supply Ops|
|James F TessmerVP:Finance & Accounting||John NorthcottVP:Marketing|